Transient flow modulation with rapid-resorbable gelatin microspheres during Yttrium-90 radioembolization for liver cancer: a preliminary clinical trial

• by Jin Woo Choi, Minseok Suh, Jae Hyun Kim, Do Hoon Kim, Myungsu Lee, Saebeom Hur, Min Uk Kim, Hyo-Cheol Kim, Hwan Jun Jae

• October 8, 2026

Author Correction: A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance

• by Christopher E. Whitehead, Elizabeth K. Ziemke, Christy L. Frankowski-McGregor, Rachel A. Mumby, June Chung, Jinju Li, Nathaniel Osher, Oluwadara Coker, Veerabhadran Baladandayuthapani, Scott Kopetz, Judith S. Sebolt-Leopold

• October 12, 2026

Parents’ Perspectives on Using Computerized Cognitive Training to Manage Cognitive Late Effects in Children With Cancer: Qualitative Descriptive Study

• by Tao Liu, Lin Mo, Feisal Hasen, Shishuang Zhou, Cho Lee Wong, XueMei Tang, Ting Han

• October 13, 2026

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

• October 15, 2026

• 1 min